So far, there is no "magic bullet" to cure HIV for good, but scientists are making rapid progress.

Switching to a long-acting cabotegravir/rilpivirine antiretroviral regimen may be safe for patients with HIV who have prior hepatitis B virus exposure, a real-world study shows.

Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. Researchers ...

Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

HIV treatment has delivered life-altering advantages. Antiretroviral therapy has led to reduced mortality and improved life expectancy for people living with HIV. Nearly 41 million people were living ...

Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...

Advocates warn the cuts to Florida’s AIDS Drug Assistance Program may increase health risks statewide and reduce access for thousands.